出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/10/22 09:44:32」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Powder, capsule and device: An imperative ménage à trois for respirable dry powders.
  • Schoubben A1, Blasi P2, Giontella A3, Giovagnoli S4, Ricci M5.
  • International journal of pharmaceutics.Int J Pharm.2015 Oct 15;494(1):40-8. doi: 10.1016/j.ijpharm.2015.08.012. Epub 2015 Aug 5.
  • OBJECTIVES: The development of inhaled products to treat or to prevent lung infection is a very active research field in drug delivery. The pulmonary route is extremely attractive but very challenging. This paper reports the study of excipient, capsule brand and device influence on the aerodynamic b
  • PMID 26255220
  • First series of patients with XDR and pre-XDR TB treated with regimens that included meropenen-clavulanate in Argentina.
  • Palmero D1, González Montaner P2, Cufré M2, García A2, Vescovo M2, Poggi S2.
  • Archivos de bronconeumologia.Arch Bronconeumol.2015 Oct;51(10):e49-e52. doi: 10.1016/j.arbres.2015.03.012. Epub 2015 May 27.
  • XDR (extensively drug-resistant) and pre-XDR tuberculosis (TB) seriously compromise prognosis and treatment possibilities, and inevitably require the use of group V drugs (World Health Organization). The progress of all patients with XDR and pre-XDR TB seen in a specialized unit during 2012 and 2013
  • PMID 26026689
  • Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
  • OʼDonnell MR1, Pillay M, Pillay M, Werner L, Master I, Wolf A, Mathema B, Coovadia YM, Mlisana K, Horsburgh CR, Padayatchi N.
  • Journal of acquired immune deficiency syndromes (1999).J Acquir Immune Defic Syndr.2015 Aug 15;69(5):536-43. doi: 10.1097/QAI.0000000000000650.
  • BACKGROUND: Capreomycin is a key antimycobacterial drug in treatment of extensively drug-resistant tuberculosis (XDR-TB). Drug-susceptibility testing (DST) for capreomycin is not routinely performed in newly diagnosed XDR-TB in South Africa. We performed this study to assess the prevalence, clinical
  • PMID 25886924


  • Mycobacterium szulgai 肺感染症の1例
  • 池上 達義,渡邊 茂樹,杉田 孝和,堀川 禎夫,鈴木 雄二郎,西山 秀樹,前川 暢夫
  • 結核 77(5), 427-431, 2002-05-15
  • … Antimicrobial susceptibility testing indicated that the isolate was sensitive to most common antimycobacterial drugs except capreomycin (CPM) and p-aminosalicylic acid (PAS), and was also sensitive to clarithromycin and fluoroquinolones including ofloxacin, levofloxacin, sparfloxacin, and ciprofloxacin. …
  • NAID 10008879622
  • Biosynthesis of capreomycin. 2. Incorporation of L-serine, L-alanine, and L-2,3-diaminopropionic acid


capreomycin /cap·reo·my·cin/ (kap″re-o-mi´sin) a polypeptide antibiotic produced by Streptomyces capreolus, which is active against human strains of Mycobacterium tuberculosis; used as the disulfate salt. cap·re·o·my·cin (kăp′rē-ō ...
Easy to read patient leaflet for capreomycin. Includes indications, proper use, special instructions, precautions, and possible side effects. ... How to use capreomycin: Use capreomycin as directed by your doctor. Check the label on ...


Google ImagesCapreomycin InjectionCapreomycin Sulfate Chemical StructureCapreomycinCapreomycin SulfateCapastat - Clinical Pharmacology

拡張検索capreomycin sulfate



capreomycin CPRM
硫酸カプレオマイシン capreomycin sulfate


  [★] カプレオマイシン capreomycin

capreomycin sulfate」

  [★] 硫酸カプレオマイシン